Therefore, the present study aimed to investigate the modulatory effects of isorhamnetin on the mRNA expression of drug-resistance-related biomarkers, focusing on various ABC transporters in SW-480 and HT-29 colon cancer cells. Here, ABCG2 is linked to colonic neoplasm.